TCS 3,483.75 -68.90 (-1.94%) 
HDFCBANK 1,745.50 +12.35 (0.71%) HINDUNILVR 2,205.65 +4.00 (0.18%) INFY 1,583.20 -25.60 (-1.59%) HDFC 2,729.95 -17.05 (-0.62%) BHARTIARTL 1,632.00 +3.85 (0.24%) KOTAKBANK 2,020.15 -14.45 (-0.71%) ICICIBANK 1,314.00 +4.40 (0.34%) ITC 404.00 -5.40 (-1.32%) BAJFINANCE 8,749.40 +69.65 (0.80%) MARUTI 11,600.00 -120.20 (-1.03%) HCLTECH 1,532.80 -25.70 (-1.65%) SBIN 747.95 +10.90 (1.48%) NESTLEIND 2,189.05 -13.40 (-0.61%) ASIANPAINT 2,279.90 +6.30 (0.28%) WIPRO 264.90 +3.50 (1.34%) DMART 3,852.45 +20.50 (0.53%) AXISBANK 1,056.35 +10.75 (1.03%) LT 3,314.95 +43.90 (1.34%) HDFCLIFE 659.80 +19.05 (2.97%) SUNPHARMA 1,734.50 -14.10 (-0.81%) ULTRACEMCO 10,867.40 +167.95 (1.57%) ONGC 232.90 +0.80 (0.34%) BAJAJFINSV 1,842.95 -2.05 (-0.11%) BPCL 265.10 +2.95 (1.13%) POWERGRID 278.00 +7.20 (2.66%) TITAN 3,077.55 -5.20 (-0.17%) BRITANNIA 4,731.00 -40.25 (-0.84%) NTPC 340.60 +3.20 (0.95%) Download Unicorn Signals App
By EquityPandit
Aurobindo Pharma has got the final approval from the US health regulator for generic version of an intravenous antidote to a pain killer drug overdose.
It said in a BSE filing that “The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Acetylcysteine Injection, 6g/30 mL (200 mg/mL) single-dose vials.”
The product is likely to be launched in the first quarter of the next fiscal.
